IMMUNIC, INC. cotiza a 7.95 USD y tiene una capitalización bursátil de $108M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | — | $-1.08 | $-0.70 |
| Estimado | $-0.96 | $-1.16 | $-0.96 | $-1.11 |
| Sorpresa | — | — | -12.5% | +36.9% |
| Métrica | IMUX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -404.0% | -32.0% | -372.0% |
| Current Ratio | 0.75 | 2.84 | -2.09 |
| Debt / Equity | — | 0.28 | — |